NYSE: CAHCardinal Health Inc Stock
$99.72+1.13 (+1.15%)
Updated May 7, 2024
CAH Price
$99.72
Fair Value Price
N/A
Market Cap
$24.29B
52 Week Low
$80.90
52 Week High
$116.04
P/E
43.74x
P/B
-7.44x
P/S
0.12x
PEG
0.54x
Dividend Yield
2.01%
Revenue
$220.57B
Earnings
$552.00M
Gross Margin
3.3%
Operating Margin
0.45%
Profit Margin
0.3%
Debt to Equity
-15.05
Operating Cash Flow
$3B
Beta
0.74
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CAH Overview
Cardinal Health, Inc. distributes pharmaceuticals and medical products to 75 percent of hospitals in the U.S. The company manufactures medical and surgical products, including gloves, surgical apparel, and fluid management products. It also operates a network of radiopharmacies. Cardinal Health was founded in 1971 and is headquartered in Dublin, OH.
Zen Score
–
Industry Average (40)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CAH scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CAH ($99.72) is trading above its intrinsic value of $76.98, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CAH is poor value based on its earnings relative to its share price (43.74x), compared to the US market average (32.4x)
P/E vs Market Valuation
CAH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CAH due diligence checks available for Premium users.
Be the first to know about important CAH news, forecast changes, insider trades & much more!
CAH News
Valuation
CAH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
43.74x
Industry
26.74x
Market
32.4x
CAH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CAH is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CAH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-7.44x
Industry
116.21x
CAH price to earnings growth (PEG)
For valuing profitable companies with growth potential
CAH is good value based... subscribe to Premium to read more.
PEG Value Valuation
CAH's financial health
Profit margin
Revenue
$54.9B
Net Income
$258.0M
Profit Margin
0.5%
CAH's Earnings (EBIT) of $995.00M... subscribe to Premium to read more.
Interest Coverage Financials
CAH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$45.9B
Liabilities
$49.1B
Debt to equity
-15.05
CAH's short-term liabilities ($36.31B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CAH's short-term assets ($35.73B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CAH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CAH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$49.0M
Investing
-$1.8B
Financing
$1.0B
CAH's operating cash flow ($2.54B)... subscribe to Premium to read more.
Debt Coverage Financials
CAH vs Medical Distribution Stocks
Cardinal Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.